In skin specifically, GHK-Cu has been extensively studied for its ability to increase collagen and elastin production, improve skin thickness and elasticity, reduce fine lines and wrinkles, improve skin firmness, reduce photodamage, reduce hyperpigmentation, and accelerate wound healing
Mechanism of Interaction: Pharmacodynamic, Not Pharmacokinetic The interaction between CoQ10 and amlodipine is pharmacodynamic
Studies show FOXO4-DRI treatment reduces senescent cell markers including p16, p21, and senescence-associated -galactosidase activity by over 50% in expanded human chondrocytes at population doubling level 9 (PDL9), the stage typically used for clinical implantation
For the best outcome, use it regularly for at least 60 days
GHK-Cu in systemic form (injection, research) has not been registered as a medicinal product in the EU, the USA or anywhere in the world